Chase AIBulk Dataset ExportPricingFAQsBlog
Display currency
Loading news…

Nivalis Therapeutics

ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).
Boulder, Colorado, United States Founded 2007 1-10 employees For Profit

Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.

Nivalis Therapeutics on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.

Nivalis Therapeutics was acquired by Alpine Immune Sciences in 2017.
Total Funding
$40M
Funding Rounds
2
Last Funding
Acquisitions
0
Monthly Visits
Contacts
3
Patents
6

About Nivalis Therapeutics

Funding & Financials

Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Delisted
Ticker
NVLS
Exchange
NASDAQ
IPO date
Jun 17, 2015
Raised at IPO
$77M
Delisted
Jul 25, 2017

Web Traffic

Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
9
Active products
15
Patents granted
6
Trademarks
0
Top patent class
a61

Company Info

Founded
2007
Employees
1-10
Operating status
Closed
Company type
For Profit
Org types
company
News articles
11
HQ
Boulder, Colorado, United States
Region
Greater Denver Area, Western US
Exit date
Jun 17, 2015

Signals & Scores

Heat score
Low
Trend (7d)
0
Trend (30d)
0.5
Trend (90d)
-0.1

Nivalis Therapeutics Funding Rounds

2 results
Upgrade to Pro to view this datasetUpgrade
Organization NameFunding TypeLead Investor NamesOrg Hq Country
1–2 of 2Show
Page 1 / 1

Nivalis Therapeutics Key People

President and Chief Executive Officer
CFO and VP Finance
3
professional contacts at Nivalis Therapeutics
Contact execs at Nivalis Therapeutics

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions
Bulk Dataset Export

Need the data in bulk? Buy the entire dataset.

5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools

Delivered as CSV, JSON or Parquet — at startup-friendly pricing.

See bulk export

FAQs about Nivalis Therapeutics

People who checked this page also checked these

Browse the full Acquirezy directory.